Literature DB >> 25201782

Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting.

Per Suppa1, Ulrich Anker2, Lothar Spies3, Irene Bopp2, Brigitte Rüegger-Frey2, Richard Klaghofer2, Carola Gocke4, Harald Hampel5, Sacha Beck2, Ralph Buchert6.   

Abstract

Hippocampal volume is a promising biomarker to enhance the accuracy of the diagnosis of dementia due to Alzheimer's disease (AD). However, whereas hippocampal volume is well studied in patient samples from clinical trials, its value in clinical routine patient care is still rather unclear. The aim of the present study, therefore, was to evaluate fully automated atlas-based hippocampal volumetry for detection of AD in the setting of a secondary care expert memory clinic for outpatients. One-hundred consecutive patients with memory complaints were clinically evaluated and categorized into three diagnostic groups: AD, intermediate AD, and non-AD. A software tool based on open source software (Statistical Parametric Mapping SPM8) was employed for fully automated tissue segmentation and stereotactical normalization of high-resolution three-dimensional T1-weighted magnetic resonance images. Predefined standard masks were used for computation of grey matter volume of the left and right hippocampus which then was scaled to the patient's total grey matter volume. The right hippocampal volume provided an area under the receiver operating characteristic curve of 84% for detection of AD patients in the whole sample. This indicates that fully automated MR-based hippocampal volumetry fulfills the requirements for a relevant core feasible biomarker for detection of AD in everyday patient care in a secondary care memory clinic for outpatients. The software used in the present study has been made freely available as an SPM8 toolbox. It is robust and fast so that it is easily integrated into routine workflow.

Entities:  

Keywords:  Alzheimer's disease; atlas-based segmentation; hippocampal volumetry; magnetic resonance imaging; memory clinic; memory impairment

Mesh:

Year:  2015        PMID: 25201782     DOI: 10.3233/JAD-141446

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

Review 2.  Structural Image Analysis of the Brain in Neuropsychology Using Magnetic Resonance Imaging (MRI) Techniques.

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2015-08-18       Impact factor: 7.444

3.  [Not Available].

Authors:  O Bartzsch
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

Review 4.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

6.  [Value and acceptance of risk assessment for Alzheimer's disease].

Authors:  O Bartzsch; J Gertheiss; P Calabrese
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

7.  Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group.

Authors:  M W Vernooij; F B Pizzini; R Schmidt; M Smits; T A Yousry; N Bargallo; G B Frisoni; S Haller; F Barkhof
Journal:  Neuroradiology       Date:  2019-03-09       Impact factor: 2.804

Review 8.  Translating research findings into clinical practice: a systematic and critical review of neuroimaging-based clinical tools for brain disorders.

Authors:  C Scarpazza; M Ha; L Baecker; R Garcia-Dias; W H L Pinaya; S Vieira; A Mechelli
Journal:  Transl Psychiatry       Date:  2020-04-20       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.